Newswise — Memorial Sloan-Kettering Cancer Center is leading an innovative initiative to reduce cancer and cardiovascular health disparities in South Asian immigrant communities in the United States. The effort, called South Asian Health: From Research to Practice and Policy, is the first comprehensive collaboration designed to engage multidisciplinary researchers, practitioners, community members, and policy makers in developing an actionable research and practice plan to improve health disparities in this population.

"This major initiative is structured to foster sustained community–academic collaboration among South Asian health researchers, academics, and community experts who have a common goal to improve this population's health outcomes on a national level," said Francesca Gany, MD, MS, Chief of the Immigrant Health and Cancer Disparities Service at Memorial Sloan-Kettering and Principal Investigator and Co-Director of the South Asian Health Initiative. "The result will be a culturally directed, translational research blueprint with recommendations that can make a measurable difference in community settings."

These experts have been actively involved in a series of ongoing work group meetings to review preliminary epidemiologic and behavioral research evidence on the most prevalent risk factors influencing cancer and cardiovascular health in the South Asian community; identify pressing gaps in the available data; and produce recommendations to address identified issues. This plan of action, or blueprint, will include the development of health-related services, research programs, and policy actions and advocacy.

The initiative, supported by the National Institutes of Health, is culminating in a daylong research conference hosted by Memorial Sloan-Kettering on September 20. South Asian health experts from around the world are expected to attend the conference, during which work groups will report on their findings and strategize approaches to facilitate them moving forward. The reports presented at the conference will be submitted to the Journal of Immigrant and Minority Health next year.

The work groups are focusing on six thematic areas that play a key role in the disproportionate rates of cardiovascular disease and certain cancers seen among South Asians in the United States. The themes include genetics and other underlying biological factors; lifestyle and common cultural behaviors related to diet, exercise, and the use of alternative medicine; inflammation, infection, and emerging research on the effect of human microbiome changes on obesity and diabetes risk; the prevalent use of alternative tobacco products and associated risk of disease; the role of cultural issues, institutional barriers, and healthcare reform on access to care; and stress and mental health issues.

The initiative is also providing opportunities for interactive community input on needed research, service, and policy priorities by engaging with the South Asian community in metropolitan areas with the largest South Asian populations, including New York City, Chicago, Washington DC, Los Angeles, the San Francisco Bay area, Atlanta, New Jersey, and Houston.

There are more than 3.4 million South Asians in the United States, representing seven countries and a wide diversity of languages and religious affiliations in the community. Recognized as the second fastest growing immigrant group in the country, many South Asians face poor healthcare access, which has been attributed to linguistic, cultural, and financial barriers, including a lack of health insurance, inadequate medical interpretation services, and inaccurate perceptions about healthcare.

For more information about the initiative and the conference agenda, go to www.mskcc.org/research/south-asian-health-research-practice-and-policy.

Memorial Sloan-Kettering Cancer Center is the world’s oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide. For more information, go to www.mskcc.org.